ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 198 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $846,000 | -73.2% | 67,923 | -70.5% | 0.00% | – |
| Q3 2016 | $3,156,000 | +191.1% | 230,578 | +57.2% | 0.00% | – |
| Q2 2016 | $1,084,000 | +44.7% | 146,645 | +25.0% | 0.00% | – |
| Q1 2016 | $749,000 | -15.7% | 117,282 | -17.6% | 0.00% | – |
| Q4 2015 | $889,000 | +653.4% | 142,286 | +604.3% | 0.00% | – |
| Q3 2015 | $118,000 | -90.0% | 20,203 | -85.9% | 0.00% | – |
| Q2 2015 | $1,185,000 | -62.9% | 143,324 | -63.1% | 0.00% | -100.0% |
| Q1 2015 | $3,196,000 | +264.8% | 387,939 | +204.1% | 0.00% | – |
| Q4 2014 | $876,000 | -48.4% | 127,567 | -59.4% | 0.00% | – |
| Q3 2014 | $1,699,000 | +94.4% | 314,573 | +129.2% | 0.00% | – |
| Q2 2014 | $874,000 | -60.5% | 137,262 | -50.0% | 0.00% | – |
| Q1 2014 | $2,212,000 | -8.5% | 274,429 | -22.5% | 0.00% | – |
| Q4 2013 | $2,417,000 | -60.7% | 354,225 | +6.1% | 0.00% | -100.0% |
| Q3 2013 | $6,145,000 | +16.9% | 333,941 | +11.1% | 0.00% | 0.0% |
| Q2 2013 | $5,257,000 | – | 300,630 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $175,916,000 | 40.51% |
| Consonance Capital Management LP | 8,695,742 | $119,045,000 | 11.46% |
| Tamarack Advisers, LP | 3,700,000 | $49,358,000 | 7.76% |
| Opaleye Management Inc. | 1,045,000 | $14,306,000 | 7.49% |
| Granite Point Capital Management, L.P. | 457,415 | $6,262,000 | 2.44% |
| Redmile Group, LLC | 2,138,471 | $29,276,000 | 2.33% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 206,010 | $2,820,000 | 2.17% |
| Palo Alto Investors LP | 2,587,617 | $35,424,000 | 2.06% |
| PRICE MICHAEL F | 940,000 | $12,869,000 | 1.71% |
| HighVista Strategies LLC | 638,086 | $8,735,000 | 1.62% |